Related Experiment Video
Updated: Jun 6, 2026
08:21
Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Effects of obesity and subsequent weight reduction on left ventricular function
1Division of Cardiology, Albany Medical Center, Albany, NY 12204, USA. LakhanM@mail.amc.edu
Cardiology in Review
|December 8, 2010
Summary
Obesity negatively impacts heart health, causing changes like increased left ventricular mass. Weight loss can reverse these effects, but combining it with beta-blockers may offer superior benefits for cardiac remodeling.
Area of Science:
- Cardiology
- Metabolic Disorders
- Vascular Biology
Background:
- Obesity is a widespread epidemic in the U.S.
- Obesity contributes to endothelial dysfunction, hypertension, and coronary artery disease.
- Adipokines released by adipose tissue are implicated in obesity-related cardiovascular damage.
Purpose of the Study:
- To examine the cardiovascular effects of obesity.
- To evaluate the impact of weight loss on cardiac structure and function.
- To investigate the role of antihypertensive therapies in conjunction with weight loss.
Main Methods:
- Review of existing literature on obesity and cardiovascular health.
- Analysis of studies on weight loss interventions (caloric restriction, surgery).
- Comparison of different antihypertensive drug classes combined with weight loss.
Main Results:
- Obesity leads to increased left ventricular (LV) mass, hypertrophy, and dilatation.
- Weight loss interventions promote "reverse remodeling," reducing LV mass and chamber size.
- Improvement in diastolic function post-weight loss is inconsistent, potentially due to nutritional factors.
Conclusions:
- Weight loss significantly improves cardiac remodeling in obese individuals.
- Combining weight loss with beta-adrenergic blocker therapy may enhance the regression of LV mass and hypertrophy compared to other antihypertensives.
- Further research is needed to optimize cardiovascular outcomes in obesity management.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...